SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news

 

 
'Naturex was a start-up 20 years ago.'

CEO Exclusive: Naturex goes back to start-up roots to drive growth

By Niamh Michail from Avignon, France , 03-Nov-2016
Last updated on 03-Nov-2016 at 15:44 GMT2016-11-03T15:44:12Z

CEO Exclusive: Naturex goes back to start-up roots to drive growth

The world’s biggest supplier of botanical extracts, Naturex, is on track to meet the targets of its growth strategy Bright2020 which aims to see 10% of sales coming from new products, according to CEO Olivier Rigaud.

“When we started Bright2020 we had roughly 4.5% of sales coming from new products launched over the past three years. [Today] we are round about between 7 and 7.5%. Knowing that we are only about nine months into the execution of Bright2020, it’s already nice,” Rigaud told us at the firm’s headquarters in Avignon, France.

In order to meet this target the company has a triple approach which involved investing in internal R&D and regional application labs for mid- to long-term growth, and a start-up accelerator scheme for more short-term results.

In terms of internal R&D, it currently has around 12 clinical studies in the works which marks “a sharp increase” over the past few years.

“Another angle is investment in application labs, which we call the Spring Labs. We have eight across the globe and we [will have] 11 by the end of next year,” said Rigaud.

The company has notably invested heavily in its application lab in Chicago and plans to open more in Singapore and Mexico by the end of next year. “This is more a collaborative approach with customers in the regions, being local and able to act fast.”

These investments are focused more on yielding long-term results, according to the CEO, as it’s difficult to know when the products will come to fruition.

'It's about keeping our roots'

Short-term innovation and products come form the third main pillar of Bright2020, its Ingenium Open Innovation, a start-up accelerator which launched around six months ago.

“It will allow us to launch faster and fill the pipeline much faster with new technologies, products and science; but also to attract some start-ups companies and talent.

“One of the targets is ‘Let’s see if we can help some entrepreneurs who fit in with the Naturex mindset' and give them a push to start [through] regulatory support, lab space, commercial support and the network in the organisation we have globally. For us it’s important because Naturex was a start-up company 20 years ago.

“It’s about keeping our roots and adding a social impact,” Rigaud added.

©iStock/rawpixelLTD

The aim of the open innovation scheme is also to attract talent from sectors the Avignon-based company has not yet explored.

Microalgae could be one, said the CEO, although he was tight-lipped about specific upcoming products in the Ingenium pipeline. However, he did say that in the space of a few months since its launch, the company has received somewhere between 300 and 400 applications. Some of the most interesting ideas had come from emerging markets, in particular related to natural colours and phytoactives.

However it has already inked a deal with Polish food supplement and pharmaceutical manufacturer Adamed through the Ingenium scheme for botanical extract chokeberry and its heart health benefits . These products will hit the shelves in 2017, said Rigaud.

Naturex reported a turnover of around €400m in 2015.

Related products

VIDEO: From earthquakes to sourcing strife - the challenges to open the world’s newest omega-3 fish oil refinery

VIDEO: From earthquakes to sourcing strife - the challenges to open the world’s newest omega-3 fish oil refinery

Omega-3 fish oil supplier SeaDragon overcame a raft of challenges to open the world's...

Nutraceutical innovation around boosting or reducing nitric oxide

Nutraceutical innovation around boosting or reducing nitric oxide

Industry interest in boosting nitric oxide, a potent vasodilator, has been increasing, with companies...

Milk protein producer not ready throw in towel to whey

Milk protein producer not ready throw in towel to whey

Milk proteins continue to carve out a strong niche in sports nutrition despite’s whey...

Just Thrive Probiotic chosen for HIV trial, company says

Just Thrive Probiotic chosen for HIV trial, company says

Thrive Probiotic has gathered data on the company’s Just Thrive Probiotic supplement and its...

Synbio ingredients have vast market penetration, new list shows

Synbio ingredients have vast market penetration, new list shows

Synthetic biology, or GMO 2.0 as some are calling it, has vastly more penetration...

FOODVISION: Trust and ethics key to reaching consumer hearts and minds

FOODVISION: Trust and ethics key to reaching consumer hearts and minds

Erin Boyd Kappelhof

Managing Partner, Eat Well Global

FOODVISION: DNA testing just ‘one part of the jigsaw’

FOODVISION: DNA testing just ‘one part of the jigsaw’

Andrew Steele

Head of Product Development, DNAFit

From marketing to taste: How virtual reality will change the food industry

From marketing to taste: How virtual reality will change the food industry

Virtual reality has arrived and is set to change the way the food industry...

Is pharma interest in probiotics a challenge or opportunity?

Is pharma interest in probiotics a challenge or opportunity?

The probiotic category continues to grow rapidly on a global basis. And with growth...

Overcoming the taboo of vaginal health – the next frontier of probiotics

Overcoming the taboo of vaginal health – the next frontier of probiotics

A paradigm shift is needed to force delicate women’s health issues like vaginal infections...

FiE 2015: Our best bits

FiE 2015: Our best bits

Our teams of journalists were out in force at Food Ingredients Europe (FiE) last...

New tech on EFSA’s horizon: Crowdsourcing and cyber assistants

New tech on EFSA’s horizon: Crowdsourcing and cyber assistants

New technology like crowdsourcing and artificial intelligence computers is the future of risk assessment,...

EFSA’s Bernhard Url: Science should reserve one private room for open debate

EFSA’s Bernhard Url: Science should reserve one private room for open debate

Since taking the European Food Safety Authority (EFSA) throne last summer, Dr Bernhard Url has become...

Seadragon sets out to breathe fire into Kiwi fish oil

Seadragon sets out to breathe fire into Kiwi fish oil

The town of Nelson will welcome New Zealand's first omega-3 fish oil processing plant...

The taste test: How do you make a probiotic drink taste good?

The taste test: How do you make a probiotic drink taste good?

Probiotic fruit drinks face different challenges to their dairy counterparts - but both face...

African probiotic project reaching 10,000 infants a day

African probiotic project reaching 10,000 infants a day

Professor Gregor Reid

Chair , University of Western Ontario & Human Microbiology and...

Germvangelist set to shake Probiota with holistic shout

Germvangelist set to shake Probiota with holistic shout

Jason Tetro

Researcher, author, The Germ Guy

Creepy proteins will be hot

New proteins are creeping on trend

Alternative proteins are a “hot area” of interest and products such as sandwich spreads...

Dairy ingredients giant on Indonesia: ‘A lot of opportunities here’

Dairy ingredients giant on Indonesia: ‘A lot of opportunities here’

Jake Riddle

General manager, Kerry Asia Pacific